Hot Pursuit     10-May-22
Biocon Ltd down for fifth straight session
Biocon Ltd is quoting at Rs 331.1, down 2.2% on the day as on 13:19 IST on the NSE. The stock tumbled 14.59% in last one year as compared to a 9.98% rally in NIFTY and a 10.19% fall in the Nifty Pharma index.

Biocon Ltd is down for a fifth straight session today. The stock is quoting at Rs 331.1, down 2.2% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.19% on the day, quoting at 16333.45. The Sensex is at 54647.08, up 0.32%.Biocon Ltd has lost around 5.76% in last one month.Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has eased around 8.7% in last one month and is currently quoting at 12785, down 1.18% on the day. The volume in the stock stood at 8.07 lakh shares today, compared to the daily average of 32.51 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 330.65, down 2.51% on the day. Biocon Ltd tumbled 14.59% in last one year as compared to a 9.98% rally in NIFTY and a 10.19% fall in the Nifty Pharma index.

The PE of the stock is 470.56 based on TTM earnings ending March 22.

Previous News
  Sensex spurts 714 pts; auto shares in demand
 ( Market Commentary - Mid-Session 09-Aug-24   10:32 )
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Biocon signs exclusive licensing and supply agreement with Handok
 ( Corporate News - 24-May-24   09:06 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
 ( Corporate News - 03-Oct-24   09:29 )
  Biocon Ltd rises for third consecutive session
 ( Hot Pursuit - 20-Aug-24   13:05 )
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon issues corporate guarantee of $20 mn for Biocon Generics
 ( Corporate News - 24-Feb-24   12:47 )
  Biocon to declare Quarterly Result
 ( Corporate News - 10-Oct-23   11:29 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
Other Stories
  Aurionpro secured digital banking transformation contract from Saudi Arabia-based bank
  11-Oct-24   16:43
  TCS slides as PAT declines to Rs 11,909 cr in Q2 FY25
  11-Oct-24   16:36
  CRISIL Ratings revises TVS Holdings' outlook to 'positive’; reaffirms 'AA' rating
  11-Oct-24   16:15
  Anand Rathi Q2 PAT climbs 32% YoY to Rs 76 cr in FY25
  11-Oct-24   16:08
  Sudarshan Chemical hits life high after arm inks pact to acquire Heubach Group’s pigment biz
  11-Oct-24   15:39
  Noel Tata named chairman of Tata Trusts
  11-Oct-24   15:30
  Reliance Power Ltd leads losers in 'A' group
  11-Oct-24   15:00
  Just Dial hits 52-week high as Q2 PAT zooms to Rs 154 crore
  11-Oct-24   14:58
  Raghav Productivity spurts after board to mull bonus issue on 18 Oct'24
  11-Oct-24   14:57
  Hercules Hoists Ltd leads losers in 'B' group
  11-Oct-24   14:45
Back Top